TW200734638A - Method for the diagnosis of thromboembolic and coronary heart diseases - Google Patents

Method for the diagnosis of thromboembolic and coronary heart diseases

Info

Publication number
TW200734638A
TW200734638A TW095136992A TW95136992A TW200734638A TW 200734638 A TW200734638 A TW 200734638A TW 095136992 A TW095136992 A TW 095136992A TW 95136992 A TW95136992 A TW 95136992A TW 200734638 A TW200734638 A TW 200734638A
Authority
TW
Taiwan
Prior art keywords
thromboembolic
coronary heart
heart diseases
diagnosis
egln2 protein
Prior art date
Application number
TW095136992A
Other languages
English (en)
Chinese (zh)
Inventor
Detlef Kozian
Matthias Herrmann
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of TW200734638A publication Critical patent/TW200734638A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095136992A 2005-10-12 2006-10-05 Method for the diagnosis of thromboembolic and coronary heart diseases TW200734638A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005048899A DE102005048899A1 (de) 2005-10-12 2005-10-12 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen

Publications (1)

Publication Number Publication Date
TW200734638A true TW200734638A (en) 2007-09-16

Family

ID=37684083

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095136992A TW200734638A (en) 2005-10-12 2006-10-05 Method for the diagnosis of thromboembolic and coronary heart diseases

Country Status (14)

Country Link
US (1) US20090197774A1 (https=)
EP (1) EP1937839B1 (https=)
JP (1) JP2009511026A (https=)
KR (1) KR20080052662A (https=)
CN (1) CN101287846A (https=)
AR (1) AR056125A1 (https=)
AT (1) ATE525481T1 (https=)
AU (1) AU2006301578B9 (https=)
BR (1) BRPI0617341A2 (https=)
CA (1) CA2625698A1 (https=)
DE (1) DE102005048899A1 (https=)
IL (1) IL190585A (https=)
TW (1) TW200734638A (https=)
WO (1) WO2007042165A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
US20100197518A1 (en) 2007-05-01 2010-08-05 Huichun Xu Methods for Diagnosing Ischemia
EP2593566B1 (en) 2010-07-14 2018-01-24 The Regents of The University of California Biomarkers for diagnosis of transient ischemic attacks
US20120065087A1 (en) 2010-07-15 2012-03-15 Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
CN104094121B (zh) * 2011-12-01 2016-10-26 霍夫曼-拉罗奇有限公司 用于诊断中风的nt-原anp和nt-原bnp
US9410204B2 (en) 2012-01-07 2016-08-09 The Regents Of The University Of California Biomarkers for diagnosing ischemia
KR101939778B1 (ko) 2012-07-27 2019-01-18 삼성전자주식회사 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치
CN119846215B (zh) * 2025-01-22 2025-07-11 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583770A4 (en) * 2002-12-20 2006-10-18 Applera Corp STENOSIS-ASSOCIATED GENETIC POLYMORPHIA, DETECTION METHOD AND ITS USE
CA2941594C (en) * 2002-12-20 2021-07-06 Celera Corporation Genetic polymorphisms of the protein receptor c (procr) associated with myocardial infarction, methods of detection and uses thereof

Also Published As

Publication number Publication date
AU2006301578B2 (en) 2011-12-01
AR056125A1 (es) 2007-09-19
DE102005048899A1 (de) 2007-04-19
IL190585A (en) 2011-12-29
BRPI0617341A2 (pt) 2011-07-26
AU2006301578A1 (en) 2007-04-19
IL190585A0 (en) 2008-11-03
US20090197774A1 (en) 2009-08-06
KR20080052662A (ko) 2008-06-11
ATE525481T1 (de) 2011-10-15
JP2009511026A (ja) 2009-03-19
CA2625698A1 (en) 2007-04-19
AU2006301578B9 (en) 2011-12-22
EP1937839A1 (de) 2008-07-02
EP1937839B1 (de) 2011-09-21
WO2007042165A1 (de) 2007-04-19
CN101287846A (zh) 2008-10-15

Similar Documents

Publication Publication Date Title
WO2004006838A3 (en) Novel kinases
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2006092668A3 (en) Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
SG161247A1 (en) Variant forms of urate oxidase and use thereof
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
DE50108974D1 (de) Mutanten der den Faktor VII aktivierenden Protease und Nachweisverfahren mit spezifischen Antikörpern
WO2003012099A1 (fr) Synthase de chondroitine
TW200724679A (en) Treatment of disease using an improved regulated expression system
UA93658C2 (en) Cell surface glycoprotein
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
WO2005110460A3 (en) Diagnosis and treatment methods related to aging, especially in muscle (14.1)
TW200741011A (en) Method for the diagnosis and treatment of cardiovascular diseases
WO2002044737A3 (en) Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor
DE60336596D1 (de) Ortspezifische verabreichung von aktiven substanzen im darm
DE602005019421D1 (de) Grosstechnisch geeigneter mikroorganismus
WO2004009028A3 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
WO2004076613A3 (de) Humane nukleinsäuresequenzen aus harnblasenkarzinomen
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
WO2008014296A3 (en) Composition and method for treatment of tumors
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2005116061A3 (de) Sequenzen für die synthese antibakteriell wirkender polyketide